Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Unlike President Trump's picks to lead other health agencies who established their conservative bona fides during the ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...